These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2694203

  • 1. HPA axis disturbance in obsessive-compulsive disorder.
    Coryell WH, Black DW, Kelly MW, Noyes R.
    Psychiatry Res; 1989 Dec; 30(3):243-51. PubMed ID: 2694203
    [Abstract] [Full Text] [Related]

  • 2. The significance of HPA axis disturbance in panic disorder.
    Coryell W, Noyes R, Schlechte J.
    Biol Psychiatry; 1989 Apr 15; 25(8):989-1002. PubMed ID: 2720018
    [Abstract] [Full Text] [Related]

  • 3. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P, Catapano F, Tortorella A, Maj M.
    Neuropsychobiology; 1997 Apr 15; 36(1):8-12. PubMed ID: 9211437
    [Abstract] [Full Text] [Related]

  • 4. FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.
    Ferrer A, Costas J, Labad J, Salvat-Pujol N, Segalàs C, Urretavizcaya M, Real E, de Arriba-Arnau A, Alonso P, Crespo JM, Barrachina M, Soriano-Mas C, Carracedo Á, Menchón JM, Soria V.
    J Psychiatr Res; 2018 Sep 15; 104():227-234. PubMed ID: 30107269
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb 15; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 6. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder.
    Gustafsson PE, Gustafsson PA, Ivarsson T, Nelson N.
    Neuropsychobiology; 2008 Feb 15; 57(1-2):14-21. PubMed ID: 18424906
    [Abstract] [Full Text] [Related]

  • 7. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder.
    Kluge M, Schüssler P, Künzel HE, Dresler M, Yassouridis A, Steiger A.
    J Psychiatr Res; 2007 Dec 15; 41(11):928-33. PubMed ID: 17049559
    [Abstract] [Full Text] [Related]

  • 8. Urinary free cortisol levels in obsessive-compulsive disorder.
    Gehris TL, Kathol RG, Black DW, Noyes R.
    Psychiatry Res; 1990 May 15; 32(2):151-8. PubMed ID: 2367600
    [Abstract] [Full Text] [Related]

  • 9. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
    Am J Psychiatry; 1989 Oct 15; 146(10):1328-30. PubMed ID: 2675643
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
    Labad J, Soria V, Salvat-Pujol N, Segalàs C, Real E, Urretavizcaya M, de Arriba-Arnau A, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Alonso P, Menchón JM.
    Psychoneuroendocrinology; 2018 Jul 15; 93():20-28. PubMed ID: 29684711
    [Abstract] [Full Text] [Related]

  • 11. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
    Psychoneuroendocrinology; 2016 Jan 15; 63():247-53. PubMed ID: 26519779
    [Abstract] [Full Text] [Related]

  • 12. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J, Insel TR.
    Biol Psychiatry; 1987 Jun 15; 22(6):667-87. PubMed ID: 3036259
    [Abstract] [Full Text] [Related]

  • 13. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM.
    Br J Psychiatry; 1992 Nov 15; 161():665-70. PubMed ID: 1422616
    [Abstract] [Full Text] [Related]

  • 14. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF.
    Biol Psychiatry; 1987 Sep 15; 22(9):1137-50. PubMed ID: 2958096
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
    Roy M, Collier B, Roy A.
    Psychiatry Res; 1990 Jan 15; 31(1):31-7. PubMed ID: 2156275
    [Abstract] [Full Text] [Related]

  • 16. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 17. The antiobsessional effects of clomipramine do not require concomitant affective disorder.
    Katz RJ, DeVeaugh-Geiss J.
    Psychiatry Res; 1990 Feb 15; 31(2):121-9. PubMed ID: 2183254
    [Abstract] [Full Text] [Related]

  • 18. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun 15; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 19. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J, Landau P, Katz R.
    Psychopharmacol Bull; 1989 Jun 15; 25(1):36-40. PubMed ID: 2672070
    [Abstract] [Full Text] [Related]

  • 20. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J, Neziroglu F, Yaryura-Tobias JA.
    Psychiatry Res; 1985 Jan 15; 14(1):85-93. PubMed ID: 3887445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.